Liquidia (LQDA) Operating Income (2020 - 2026)
Liquidia's (LQDA) quarterly Operating Income came in at $61.5 million in Q1 2026, up 273.62% year-on-year from $16.5 million in Q1 2025, and up 210.83% quarter-over-quarter from $19.8 million in Q4 2025.
Liquidia (LQDA) Operating Income (2020 - 2026) Analysis & Trends
Liquidia's Operating Income history runs 7 years deep, the most recent figure standing at $61.5 million for Q1 2026.
- On a quarterly basis, Operating Income rose 273.62% year-over-year to $61.5 million in Q1 2026; TTM through Mar 2026 was $45.6 million, a 135.61% increase from a year earlier, with the FY2025 full-year figure at -$51.4 million, up 57.64% from the prior year.
- Operating Income grew to $61.5 million in Q1 2026 per LQDA's latest filing, from $19.8 million in the prior quarter.
- Across five years, Operating Income topped out at $61.5 million in Q1 2026 and bottomed at -$37.5 million in Q2 2025.
- The 5-year median for Operating Income is -$14.9 million (2023), against an average of -$13.1 million.
- Across the five-year window, Operating Income sank 306.9% in 2023 and jumped 273.62% in 2026, its largest moves.
- Year by year, Operating Income stood at -$6.5 million in 2022, then sank by 306.9% to -$26.4 million in 2023, then tumbled by 36.58% to -$36.1 million in 2024, then surged by 154.8% to $19.8 million in 2025, then jumped by 210.83% to $61.5 million in 2026.
- Per Business Quant, the three latest LQDA Operating Income figures stand at $61.5 million (Q1 2026), $19.8 million (Q4 2025), and $1.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 325.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Liquidia | 7.61 Bn | 7.38 Bn | 121.79 Mn | 61.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.50 Mn |
| Dec 31, 2025 | 19.79 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | -37.51 Mn |
| Mar 31, 2025 | -35.43 Mn |
| Dec 31, 2024 | -36.11 Mn |
| Sep 30, 2024 | -29.19 Mn |
| Jun 30, 2024 | -27.20 Mn |
| Mar 31, 2024 | -28.80 Mn |
| Dec 31, 2023 | -26.44 Mn |
| Sep 30, 2023 | -14.89 Mn |
| Jun 30, 2023 | -22.83 Mn |
| Mar 31, 2023 | -9.23 Mn |
| Dec 31, 2022 | -6.50 Mn |
| Sep 30, 2022 | -8.83 Mn |
| Jun 30, 2022 | -8.97 Mn |
| Mar 31, 2022 | -14.47 Mn |
| Dec 31, 2021 | -11.36 Mn |
| Sep 30, 2021 | -7.08 Mn |
| Jun 30, 2021 | -6.35 Mn |